Time to abandon testing for microscopic haematuria in adults?
Abstract
Methods I was one of a panel of Swedish general practitioners and urologists set up by National Board of Health and Welfare in Sweden 1999 to formulate evidence based policy statements and recommendations for evaluating microhaematuria in adults. The panel recommended that testing for microhaematuria should be abandoned. This article continues that work and is based on an updated computer aided literature search up to May 2002 aimed at addressing four key questions: What is the significance of asymptomatic microhaematuria (compared with a control group with a negative test)? What diseases do we want to diagnose with this test? What is the efficacy of testing for microhaematuria in populations at high risk? What is the diagnostic significance of microhaematuria in patients with pain in the loin or lower urinary tract symptoms?Keywords
This publication has 30 references indexed in Scilit:
- Evidence based case report: Asymptomatic haematuria ... in the doctorBMJ, 2000
- RAPID PROTECTION OF BLADDER CANCER: A COMPARATIVE STUDY OF POINT OF CARE TESTSJournal of Urology, 1997
- A Multicenter Trial Evaluation of the Fibrin/Fibrinogen Degradation Products Test for Detection and Monitoring of Bladder CancerJournal of Urology, 1997
- Microscopic haematuria: urological investigation using a standard protocolBritish Journal of Urology, 1996
- Evaluation of asymptomatic microhematuriaUrology, 1995
- Hematuria Home Screening: Repeat Testing ResultsJournal of Urology, 1995
- Time Lag to Diagnosis of Bladder Cancer–Influence of Psychosocial Parameters and Level of Health-Care ProvisionScandinavian Journal of Urology and Nephrology, 1993
- Microscopic Haematuria as a Predictor of Urological Diseases among Steel WorkersOccupational Medicine, 1990
- Dipstick haematuria and bladder cancer in men over 60: results of a community study.BMJ, 1989
- Costs of unnecessary tests.BMJ, 1979